NIAID Development of: Vaccine Candidates, Therapeutic Candidates, In Vitro Diagnostics for: Biodefense, Antimicrobial Resistance, Emerging Infectious Diseases

Sponsor Deadline: 

Apr 18, 2022

Sponsor: 

NIH National Institute of Allergy and Infectious Diseases

UI Contact: 

NIAID 2022 OMNIBUS BROAD AGENCY ANNOUNCEMENT (BAA)
HHS-NIH-NIAID-BAA2022-1
Sam.gov   https://sam.gov/opp/7be6deac410e4e4789555c72254d3f4d/view?utm_campaign=%2050765159&utm_content=&utm_medium=email&utm_source=govdelivery&utm_term=
 

Research Area 001 - Development of Vaccine Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
Proposals Due Date and Time - 3:00 PM Eastern Time on April 18, 2022

Research Area 002 - Development of Therapeutic Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
Proposals Due Date and Time - 3:00 PM Eastern Time on April 18, 2022

Research Area 003 - The Antiviral Program for Pandemics (APP): Development of Antivirals for Specific RNA Viral Families of Pandemic Potential 
Proposals Due Date and Time - 3:00 PM Eastern Time on March 18, 2022

Research Area 004 - Development of In Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (AMR), and Emerging Infectious Diseases 
Proposals Due Date and Time - 3:00 PM Eastern Time on April 18, 2022

Categories: